annual accounts payable:
$3.18B+$1.06B(+50.34%)Summary
- As of today (May 29, 2025), TAK annual accounts payable is $3.18 billion, with the most recent change of +$1.06 billion (+50.34%) on March 1, 2025.
- During the last 3 years, TAK annual accounts payable has risen by +$753.45 million (+31.08%).
- TAK annual accounts payable is now at all-time high.
Performance
TAK Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$3.18B+$247.61M(+8.45%)Summary
- As of today (May 29, 2025), TAK quarterly accounts payable is $3.18 billion, with the most recent change of +$247.61 million (+8.45%) on March 1, 2025.
- Over the past year, TAK quarterly accounts payable has increased by +$1.06 billion (+50.34%).
- TAK quarterly accounts payable is now -7.34% below its all-time high of $3.43 billion, reached on December 31, 2023.
Performance
TAK quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TAK Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.3% | +50.3% |
| 3 y3 years | +31.1% | +31.1% |
| 5 y5 years | +62.3% | +62.3% |
TAK Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.3% | -7.3% | +50.3% |
| 5 y | 5-year | at high | +62.3% | -7.3% | +62.3% |
| alltime | all time | at high | +644.8% | -7.3% | +296.1% |
TAK Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $3.18B(+50.3%) | $3.18B(+8.4%) |
| Dec 2024 | - | $2.93B(+1.3%) |
| Sep 2024 | - | $2.89B(-0.7%) |
| Jun 2024 | - | $2.91B(+37.8%) |
| Mar 2024 | $2.11B(-8.4%) | $2.11B(-38.4%) |
| Dec 2023 | - | $3.43B(+21.7%) |
| Sep 2023 | - | $2.82B(-7.4%) |
| Jun 2023 | - | $3.05B(+32.0%) |
| Mar 2023 | $2.31B(-4.8%) | $2.31B(-20.6%) |
| Dec 2022 | - | $2.91B(+8.1%) |
| Sep 2022 | - | $2.69B(-13.4%) |
| Jun 2022 | - | $3.11B(+28.1%) |
| Mar 2022 | $2.42B(+15.2%) | $2.42B(-20.6%) |
| Dec 2021 | - | $3.05B(+1.5%) |
| Sep 2021 | - | $3.01B(+3.7%) |
| Jun 2021 | - | $2.90B(+37.9%) |
| Mar 2021 | $2.10B(+7.4%) | $2.10B(-33.6%) |
| Dec 2020 | - | $3.17B(+22.8%) |
| Sep 2020 | - | $2.58B(-4.1%) |
| Jun 2020 | - | $2.69B(+37.5%) |
| Mar 2020 | $1.96B(+2.2%) | $1.96B(-28.9%) |
| Dec 2019 | - | $2.75B(+6.0%) |
| Sep 2019 | - | $2.60B(+0.5%) |
| Jun 2019 | - | $2.58B(+35.0%) |
| Mar 2019 | $1.92B(+52.2%) | $1.92B(-15.0%) |
| Dec 2018 | - | $2.25B(+13.5%) |
| Sep 2018 | - | $1.99B(-2.7%) |
| Jun 2018 | - | $2.04B(+62.2%) |
| Mar 2018 | $1.26B(-41.5%) | $1.26B(-36.5%) |
| Dec 2017 | - | $1.98B(+6.3%) |
| Sep 2017 | - | $1.86B(-4.9%) |
| Jun 2017 | - | $1.96B(-8.9%) |
| Mar 2017 | $2.15B(+26.6%) | $2.15B(+8.0%) |
| Dec 2016 | - | $1.99B(+2.5%) |
| Sep 2016 | - | $1.94B(+5.1%) |
| Jun 2016 | - | $1.85B(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | $1.70B(+19.5%) | $1.70B(+20.2%) |
| Dec 2015 | - | $1.41B(+7.6%) |
| Sep 2015 | - | $1.32B(-6.7%) |
| Jun 2015 | - | $1.41B(-1.0%) |
| Mar 2015 | $1.42B(-20.8%) | $1.42B(+0.9%) |
| Dec 2014 | - | $1.41B(-0.6%) |
| Sep 2014 | - | $1.42B(-7.0%) |
| Jun 2014 | - | $1.53B(-15.1%) |
| Mar 2014 | $1.80B(-0.4%) | $1.80B(+53.4%) |
| Dec 2013 | - | $1.17B(+6.2%) |
| Sep 2013 | - | $1.10B(+2.1%) |
| Jun 2013 | - | $1.08B(-40.1%) |
| Mar 2013 | $1.80B(-15.7%) | $1.80B(+42.8%) |
| Dec 2012 | - | $1.26B(+0.1%) |
| Sep 2012 | - | $1.26B(+0.7%) |
| Jun 2012 | - | $1.25B(-41.4%) |
| Mar 2012 | $2.14B(+121.6%) | $2.14B(+69.7%) |
| Dec 2011 | - | $1.26B(+7.6%) |
| Sep 2011 | - | $1.17B(+25.0%) |
| Jun 2011 | - | $937.32M(-2.9%) |
| Mar 2011 | $965.45M(-53.9%) | $965.45M(-4.8%) |
| Dec 2010 | - | $1.01B(+12.8%) |
| Sep 2010 | - | $899.30M(+8.3%) |
| Jun 2010 | - | $830.46M(-60.3%) |
| Mar 2010 | $2.09B(-13.2%) | $2.09B(+161.0%) |
| Dec 2009 | - | $802.41M(-0.9%) |
| Sep 2009 | - | $809.63M(-66.4%) |
| Mar 2009 | $2.41B(+232.5%) | $2.41B(+190.0%) |
| Dec 2008 | - | $831.72M |
| Mar 2008 | $725.37M(+55.0%) | - |
| Mar 2007 | $467.98M(+8.7%) | - |
| Mar 2006 | $430.60M(+0.9%) | - |
| Mar 2005 | $426.71M(-15.5%) | - |
| Mar 2004 | $505.15M(+9.6%) | - |
| Mar 2003 | $461.04M(+7.6%) | - |
| Mar 2002 | $428.47M(-40.7%) | - |
| Mar 2001 | $722.26M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual accounts payable?
- What is the all time high annual accounts payable for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual accounts payable year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly accounts payable year-on-year change?
What is Takeda Pharmaceutical Company Limited annual accounts payable?
The current annual accounts payable of TAK is $3.18B
What is the all time high annual accounts payable for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual accounts payable is $3.18B
What is Takeda Pharmaceutical Company Limited annual accounts payable year-on-year change?
Over the past year, TAK annual accounts payable has changed by +$1.06B (+50.34%)
What is Takeda Pharmaceutical Company Limited quarterly accounts payable?
The current quarterly accounts payable of TAK is $3.18B
What is the all time high quarterly accounts payable for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly accounts payable is $3.43B
What is Takeda Pharmaceutical Company Limited quarterly accounts payable year-on-year change?
Over the past year, TAK quarterly accounts payable has changed by +$1.06B (+50.34%)